Oral Session 3-5B T cell therapy

[OS3-5B-6] Usefulness of tetramer assay and adoptive transfer of EBV specific CTLs to manage PTLD

Nobuhiro Nishio^1,2, Shunsuke Miwata¹, Kotaro Narita¹, Hironobu Kitazawa¹, Shinsuke Kataoka¹, Motoharu Hamada¹, Daisuke Ichikawa¹, Rieko Taniguchi¹, Norihiro Murakami¹, Kyogo Suzuki¹, Nozomu Kawashima¹, Eri Nishikawa¹, Yusuke Okuno^1,2, Atsushi Narita¹, Hideki Muramatsu¹, Ritsuro Suzuki³, Takehiko Mori⁴, Hiroshi Kawabata⁵, Seiji Kojima¹, Yoshiyuki Takahashi¹ (1.Department of Pediatrics, Nagoya University Hospital, Nagoya, Japan, 2.CAMCR, Nagoya University Hospital, Japan, 3.Department of Oncology and Hematology, Shimane University Hospital, Izumo, Japan, 4.Division of Hematology, Department of Medicine, Keio University, Tokyo, Japan, 5.Hematol/Oncol, Kyoto Univ, Kyoto, Japan)